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Abstracts / Osteoarthritis and Cartilage 23 (2015) A26eA81 A35improvements were larger in theMEDIC group in pain intensity after 30
min of walking and in the number of body sites with pain (P < 0.05).
There was no difference in pain pattern, usage of pain medication or in
the change in sensitization from baseline to 3 months between groups
(P > 0.05), but sensitization improved in both groups P < 0.05).
Conclusions: A multimodal non-surgical treatment program is more
efﬁcacious in reducing self-reported pain-related measures, while it is
not superior to usual care in reducing pain sensitization. This suggests
that other mechanisms than pain sensitization contributed to the per-
ception of pain.Table 1
Baseline characteristics
Baseline characteristics MEDIC (n¼50) Usual care (n¼50)
Women, n (%) 26 (52) 25 (50)
Age (years), mean (SD) 64.8 (8.7) 67.1 (9.1)
Body Mass Index, mean (SD) 30.6 (5.6) 29.4 (5.2)
Radiographic knee OA severity
(Kellgren-Lawrence), n (%)
Grade 1 7 (14) 11 (22)
Grade 2 13 (26) 15 (30)
Grade 3 13 (26) 10 (20)
Grade 4 17 (34) 14 (28)
Peak pain intensity in the previous
24h (VAS 0-100), mean (SD)
60 (23) 56 (25)18
MRI STRUCTURAL PARAMETERS PREDICT SHORT TERM RESPONSE
TO INTRA-ARTICULAR STEROID THERAPY IN KNEE OA
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Purpose: Osteoarthritis (OA) is a disease of the whole joint. Intra-
articular steroid injection (IASI) is widely used in the management of
knee OA; however, it remains unclear whether structural factors iden-
tiﬁed by magnetic resonance imaging (MRI) may inﬂuence outcome of
therapy. The aim of this analysis was to determine if individual sub-
scores of WORMS assessed prior to IASI of the knee including scores for
cartilage, bone attrition, bone marrow lesions (BMLs), synovitis,
osteophytes, bone cyst, menisci and ligaments, inﬂuence short-term
response to treatment.
Methods: Men and women aged 40 years and older with painful knee
OA who met the American College of Rheumatology criteria for the
disease, were recruited for participation in an open-label clinical trial of
IASI. Subjects who took part in the study had signiﬁcant knee pain
(moderate to severe pain on at least 2 days in the last 2 weeks and/or
Knee Injury and Osteoarthritis Outcome Score (KOOS) pain subscale >
7) and knee OA; on radiographs at least a Kellgren-Lawrence grade 2 or
more. At baseline they completed questionnaires about their symptomsincluding the KOOS (0-100) with lower scores indicating greater pain
and also a VAS (0-10cm) for pain during a nominated activity (VASNA)
with higher scores indicating greater pain. They subsequently had a
gadolinium (Gd)-enhanced MRI scan using 3-T scanner immediately
prior to having an IASI (depomedrone 80mg) with follow-up visit
usually within a 2-week period. Semi-quantitative grading of the MRI
images using the WORMS protocol was performed for cartilage, bone
attrition, BMLs, synovitis, osteophytes, bone cysts, menisci and liga-
ments within the knee by an experiencedMSK radiologist. For cartilage,
bone attrition, BMLs, osteophytes and bone cyst we focused our anal-
yses on the maximal WORMS score in any region of the knee. Using
linear regression we looked whether these WORMS scores at baseline
were associated with the change in KOOS pain and VASNAbetween
baseline and the follow-up visit, with the results expressed as b
(unstandardised) coefﬁcients and 95% conﬁdence intervals (CI).
Results: 112 participants recruited at baseline had MRI images eval-
uated. Their mean agewas 61.8 years (SD¼10.2 years) and 57 (51%) were
female. The median time between baseline and the follow-up visit was
8 days (IQR 7 to 13 days). During this time there was a signiﬁcant
increase in KOOS (23.0 points; 95% CI 19.0, 27.0) and a reduction in
VASNA (-3.1cm; 95% CI -3.7, -2.6), both indicating an improvement in
pain following steroid injection. Using linear regression, we found that
higher maximal score for BMLs (b coefﬁcient¼ 0.79; 95%CI 0.19, 1.38),
and menisci damage (b coefﬁcient¼ 0.35; 95% CI 0.03, 0.68) were
associated with a smaller reduction in pain as assessed by VASNA
VASnA. Similar trends were observed when KOOS pain was used as the
outcome(data not shown).
Conclusions: To our knowledge, this is the ﬁrst trial that has looked at
WORMS individual structural sub-scores to predict response to IASI.
Persons with more severe structural disease are less likely to have pain
reduction with steroid injection as assessed by MRI markers of disease
severity.
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SUPERVISED NEUROMUSCULAR EXERCISE PRIOR TO HIP OR KNEE
REPLACEMENT: COST-UTILITY ANALYSIS ALONGSIDE A
RANDOMISED CONTROLLED TRIAL
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Purpose: To analyse cost-utility of supervised neuromuscular exercise
prior to total hip replacement (THR) and total knee replacement (TKR).
Methods: Cost-utility analysis was performed alongside a randomised
controlled trial including 165 patients scheduled for THR or TKR
(Clinical Trials registration no.: NCT01003756). An 8-week preoperative
supervised neuromuscular exercise program was provided twice
weekly in addition to standard THR or TKR regimen compared to
standard THR and TKR regimen alone. The analysis applied the health
care sector perspective and used the intention-to-treat approach. The
intervention cost was based on tariff-based costs for physiotherapy.
Individual resource use and tariff-based costs (2012-EUR) for health
care visits in primary and secondary care were extracted from The
Danish National Health Insurance Service Registry and The Danish
National Health Registry. Utility was expressed as quality adjusted life
years (QALY), based on weighted EQ-5D-3L scores. Missing EQ-5D-3L
data was imputed with the linear trend at point method. Incremental
net monetary beneﬁt was analysed to estimate the probability for the
intervention being cost effective and presented in cost effectiveness
acceptability curve (CEAC). The robustness of the cost-utility result was
tested by changing perspective, applying a per-protocol analysis and
limiting analysis to complete item response. The time horizon was 61
weeks including assessment of clinical outcomes at baseline, post-
intervention, and 6 weeks, 3 months and 12 months post-surgery.
Results: A non-signiﬁcant total cost of V132 (95% CI -3942 to 3679) was
observed between the groups. There was a signiﬁcant QALY gain of 0.06
(95% CI, 0.02 to 0.09) in the intervention group as compared to the
control group. At the conventional threshold of V40.000, the inter-
ventionwas found to be cost effective at 89% probability. The cost-utility
analysis was found to be robust (Figure).
Conclusions: Preoperative supervised neuromuscular exercise was
cost-effective in patients scheduled for THR and TKA surgery at con-
ventional thresholds for willingness to pay.
